Cambridge Cognition wins £1.37 million of new eCOA contracts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has today announced that the Company has won a contract for three phase II studies with a new pharmaceutical client.  The Directors believe these studies, which have an aggregate value to the Company of £1.37 million, demonstrate significant progress for the Company in delivering its strategy of combining the sale of CANTAB™ cognitive assessments with additional electronic clinical outcome assessments (eCOA).  Contract delivery is expected to be over a two year period.

The Company will provide the Client with a single vendor solution for all three studies, managing the procurement of licences, device provision, CANTABTM cognitive assessments, a centralised platform for data acquisition and storage, as well as trial management services.  The Client and the Company will additionally collaborate on the design and testing of a new cognitive task for use in clinics.  The contract also includes the provision of one-to-one training for study sites, as well as the licensing of eCOA instruments.  These additional services, which amount to 44% of the contract value, will be provided by a subcontractor to Cambridge Cognition.

The three studies will include a total of 180 patients – 60 per clinical group – with the overall objective being to track early cognitive changes and motor signals associated with the drug being delivered.  By delivering CANTABTM cognitive assessments and eCOA questionnaires and scales all one platform, the Client will be able to sensitively, efficiently and securely monitor three distinct clinical populations.  

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“We are pleased to welcome another pharmaceutical partner to our growing client base, using our innovative digital health technologies.  This is the second partnership that has been secured on the strength of launching our enhanced eCOA solution in 2019; underlining the importance of continuing to invest in developing our digital solutions.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions